Issue Date
--
Investment/lot
--
Price Range
--
Lot Size
--
IPO Size
N/A
Start date
End date
Allotment of bids
Refund Initiation
Listing on exchange
Satol Chemicals Limited IPO is an IPO of up to 42,00,000 equity shares aggregating to ₹30.24 crores. It consists of a fresh issue of up to 42,00,000 equity shares aggregating to ₹30.24 crores. The shares will be allotted on TBA. The credit of shares to the demat account will take place on TBA, and the initiation of refunds will take place on TBA.
Part funding of capital expenditure towards setting up a new manufacturing facility.
General corporate purposes.
Detail | Information |
---|---|
Upper Price Band (₹) | TBA |
Existing Shares to be Sold | - |
Fresh Issue | Up to 42,00,000 Equity Shares |
EPS (₹) For the year ended March 31, 2024 | 9.18 |
Investor Category | Shares Offered |
---|---|
QIBs Share Offered | - |
Non-Institutional Investors (NIIs) | - |
Retail Individual Investors | - |
India's chemical sector, which is worth US$ 22,000 crores currently, is anticipated to grow to US$ 30,000 crores by 2030 and US$ 1,00,000 crores by 2040. The demand for chemicals is expected to expand by 9% per annum by 2025. The Indian chemical industry is expected to further grow with a CAGR of 11-12% by 2027, increasing India's share in the global specialty chemicals market to 4% from 3%.
Satol Chemicals Limited is an ISO 9000:2015 and GMP-certified manufacturer specialising in eco-friendly specialty chemicals, delivering high-quality, effective, and safe cleaning solutions. Their industrial range includes alkaline and acidic cleaners, lubricants, descalers, foam cleaners, defoamer, antiscalants and disinfectants. Additionally, their house-keeping products encompass bathroom and floor cleaners, shampoos, detergent powders, fabric softeners, glass cleaners, grill cleaners, and room fresheners. In the drug and cosmetic segment, they offer premium hand washes, hand sanitisers, germicidal cleaners, and disinfectant floor cleaners, ensuring top-tier quality and safety across all their product lines.
A Diversified Product Portfolio Catering to Industry Needs Satol Chemicals Limited prides itself on offering a diversified product portfolio that addresses the unique requirements of a wide range of industries. Their products are designed to meet the spec
Strong R&D capabilities and Excellence in Quality Control A key strength of their company lies in our fully operational Quality Control Laboratory and dedicated Research & Development (R&D) Department, both staffed by highly experienced professionals. The
Efficient Effluent and Logistic Management Their state-of-the-art manufacturing facility is strategically located in the Sarigam Industrial Estate, part of the Gujarat Industrial Development Corporation (GIDC), an area renowned for its accessibility and i
The company, directors, promoters and group companies are parties to certain legal proceedings. Any adverse decision in such proceedings may have a material adverse effect on our business, results of operations and financial condition.
They may face several risks associated with setting up a new manufacturing unit, which could hamper their growth prospects, cash flows and business and financial condition.
The company has had negative cash flow in recent fiscals. Sustained negative cash
Flow could adversely impact their business, financial condition and results of operations.
Particulars (in Rs. crores)
Particulars (in Rs. crores)
Parameter | Satol Chemicals Limited | Rossari Biotech Limited | Chembond Chemicals Limited |
---|---|---|---|
Turnover March 31, 2024 (₹ in crores) | 47.413 | 120.291 | 52.596 |
P/E | 7.84 | 45.75 | 106.14 |
EPS (Basic)(₹) | 9.18 | 18.05 | 5.38 |
Return on Net Worth (%) | 69.28% | 10.37% | 2.92% |
NAV per share (₹) | 16.07 | 17.38 | 182.12 |
Anchor Investor Information
IPO Registrar and Book Running Lead Managers
Book running lead managers:
Finshore Management Services Limited
Registrar for the IPO is KFin Technologies Limited
The company earns its revenue by offering the following products:
The total revenue, comprising both revenue from operations and other income, has risen to ₹47.42 crores in FY 2023-24, up from ₹42.28 crores in FY 2022-23. This represents an increase of ₹5.15 crores, or 12.18% for the said period, mainly driven by a growth in revenue from operations during the fiscal year.
In recent years, Satol Chemicals Limited has expanded beyond national borders, establishing its foothold in the international market. They have started exporting their products to neighbouring countries and other nations within Asia, signalling the beginning of their global expansion. This strategic move not only enhances their market presence but also opens new growth opportunities in the competitive international arena.
Parameter | FY22 | FY23 | FY24 |
---|---|---|---|
Revenue from operations (₹ crores) | 17.097 | 42.263 | 47.413 |
Profit Before Tax (₹ crores) | 0.766 | 2.419 | 6.772 |
Net profit / (loss) (₹ crores) | 0.6582 | 1.948 | 5.5195 |
EBITDA (₹ crores) | 1.005 | 3.004 | 7.415 |
EPS (₹) | 1.10 | 3.24 | 9.18 |
Parameter | FY22 | FY23 | FY24 |
---|---|---|---|
Profit before tax (₹crores) | 0.766 | 2.419 | 6.772 |
Net Cash from Operating Activities (₹ crores) | (4.778) | 1.063 | 1.844 |
Net Cash from Investing Activities (₹ crores) | (1.001) | (0.228) | (1.143) |
Net Cash from Financing Activities (₹ crores) | 5.802 | (0.824) | (0.653) |
Cash and Cash Equivalents (₹ crores) | 0.024 | 0.010 | 0.048 |
You can check the allotment status of shares either on the website of the Bombay Stock Exchange (BSE) or on the website of the registrar KFin Technologies Limited. To check the status on the BSE website:
Follow these steps to know the allotment status on the registrar’s website:
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
The Satol Chemicals Limited IPO has an issue size of up to 42,00,000 equity shares aggregating to ₹30.24 crores. The IPO opens for subscription on TBA and closes on TBA.
KFin Technologies Limited is the registrar for this IPO.
You may read more about Satol Chemicals Limited and its IPO from the company’s draft red herring prospectus (DRHP) here.